- SG$1.88bn
- SG$1.75bn
- SG$706.92m
- 68
- 46
- 53
- 59
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 23.7 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | -3.08% | ||
| Dividend Yield (f) | 2.51% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.83 | ||
| Price to Tang. Book | 1.86 | ||
| Price to Free Cashflow | 11.23 | ||
| Price to Sales | 2.66 | ||
| EV to EBITDA | 12.05 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 10.08% | ||
| Return on Equity | 8.84% | ||
| Operating Margin | 16.37% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SG$m | 522.04 | 568.2 | 723.79 | 822.92 | 706.92 | 707.95 | 745.99 | 7.64% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -16.85 | +14.07 | +16.84 | +83.96 | -45.04 | -6.29 | +4.76 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Raffles Medical Group Ltd is a Singapore-based integrated private healthcare provider. The principal activities of the Company are those relating to the operation of medical clinics, other general medical services, and investment holdings. The Company’s segments include Healthcare Services, Hospital Services, and Investment Holdings. The Healthcare Services segment is engaged in the operations of medical clinics and other general medical services; provision of health insurance, trading in pharmaceutical and nutraceutical products and diagnostic equipment, and provision of management and consultancy services. The Hospital Services segment is engaged in the provision of specialized medical services and operation of hospital and business of medical laboratory and imaging center. The Investment Holdings segment is engaged in investment holding and those relating to investment properties. It operates medical facilities in about 14 cities in Singapore, China, Japan, Vietnam, and Cambodia.
Directors
- Choon Yong Loo CHM (71)
- Won Lein Ng CFO (53)
- Kah Ling Teo CIO
- Vincent Chia DMD
- Ee Rong Chong DMD
- Kenneth Wu DMD
- Juliet Khew GMG
- Yih Ming Yong GMG
- Kimmy Goh CTR
- Lu Qinghui Sarah EDR (39)
- Soo Nan Tan EDR (73)
- Abdul Razakjr Bin Omar OTH
- Shih Kiat Chng OTH
- Pauline Chua OTH
- Kai Meng Hoo OTH
- Lau Keith OTH
- Nandha Kumar OTH
- I Wuen Lee OTH
- Jong Jian Lee OTH
- Michael Lee OTH
- Stanley Liew OTH
- Alfred Loh OTH
- Lena Motoda OTH
- Salleh Omar OTH
- Yoichi Onishi OTH
- Charles Poon OTH
- Soon Neo Tan OTH (55)
- Walter Tan OTH
- Melvyn Wong OTH
- Michael Wong OTH
- Wei Mon Wong OTH
- Wilson Wong OTH
- Ching Yu Yang OTH
- Poh Tiong Koh LED (74)
- Tse Ghow Lim NED (56)
- Teik Lim Ang NID (68)
- Chuan Neo Chong NID (58)
- Teck Koon Kee NID (65)
- Yoong Keong Lew NID (65)
- Siang Keat Lim NID (61)
- Cheong Boon Png NID (51)
- Jao Yiu Sung NID (62)
- Wern Yuen Tan NID (43)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- May 16th, 1989
- Public Since
- April 11th, 1997
- No. of Shareholders
- 15,430
- No. of Employees
- 2,892
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Singapore Exchange Securities Trading Ltd- Shares in Issue
- 1,861,503,625
- Address
- 585 North Bridge Road, 188770
- Web
- https://www.rafflesmedicalgroup.com/
- Phone
- +65 63111111
- Auditors
- KPMG LLP
Latest News for BSL
Upcoming Events for BSL
Raffles Medical Group Ltd Annual Shareholders Meeting
Raffles Medical Group Ltd Annual Shareholders Meeting
Dividend For RAFG.SI - 0.0240 SGD
Half Year 2024 Raffles Medical Group Ltd Earnings Release
Similar to BSL
Alliance Healthcare
Singapore Exchange Securities Trading Ltd
Aoxin Q & M Dental
Singapore Exchange Securities Trading Ltd
Asiamedic
Singapore Exchange Securities Trading Ltd
Asia Vets Holdings
Singapore Exchange Securities Trading Ltd
Beverly JCG
Singapore Exchange Securities Trading Ltd
FAQ
As of Today at 19:17 UTC, shares in Raffles Medical are trading at SG$1.01. This share price information is delayed by 15 minutes.
Shares in Raffles Medical last closed at SG$1.01 and the price had moved by -30.82% over the past 365 days. In terms of relative price strength the Raffles Medical share price has underperformed the FTSE Developed Asia Pacific Index by -27.79% over the past year.
The overall consensus recommendation for Raffles Medical is Hold. You can view the full broker recommendation list by unlocking its StockReport.
The Raffles Medical dividend yield is 2.38% based on the trailing twelve month period.
Last year, Raffles Medical paid a total dividend of SG$0.02, and it currently has a trailing dividend yield of 2.38%.Looking ahead, shares in Raffles Medical are due to go ex-dividend on 2024-05-13 and the next dividend pay date is 2024-05-23.
Raffles Medical are due to go ex-dividend on 2024-05-13 and the next dividend pay date is 2024-05-23. The historic dividend yield on Raffles Medical shares is currently 2.38%.
To buy shares in Raffles Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SG$1.01, shares in Raffles Medical had a market capitalisation of SG$1.88bn.
Here are the trading details for Raffles Medical:
- Country of listing: Singapore
- Exchange: SES
- Ticker Symbol: BSL
Based on an overall assessment of its quality, value and momentum Raffles Medical is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Raffles Medical is SG$1.15. That is 13.56% above the last closing price of SG$1.01.
Analysts covering Raffles Medical currently have a consensus Earnings Per Share (EPS) forecast of SG$0.04 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Raffles Medical. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -21.52%.
As of the last closing price of SG$1.01, shares in Raffles Medical were trading -11.28% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Raffles Medical PE ratio based on its reported earnings over the past 12 months is 23.7. The shares last closed at SG$1.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Raffles Medical's management team is headed by:
- Choon Yong Loo - CHM
- Won Lein Ng - CFO
- Kah Ling Teo - CIO
- Vincent Chia - DMD
- Ee Rong Chong - DMD
- Kenneth Wu - DMD
- Juliet Khew - GMG
- Yih Ming Yong - GMG
- Kimmy Goh - CTR
- Lu Qinghui Sarah - EDR
- Soo Nan Tan - EDR
- Abdul Razakjr Bin Omar - OTH
- Shih Kiat Chng - OTH
- Pauline Chua - OTH
- Kai Meng Hoo - OTH
- Lau Keith - OTH
- Nandha Kumar - OTH
- I Wuen Lee - OTH
- Jong Jian Lee - OTH
- Michael Lee - OTH
- Stanley Liew - OTH
- Alfred Loh - OTH
- Lena Motoda - OTH
- Salleh Omar - OTH
- Yoichi Onishi - OTH
- Charles Poon - OTH
- Soon Neo Tan - OTH
- Walter Tan - OTH
- Melvyn Wong - OTH
- Michael Wong - OTH
- Wei Mon Wong - OTH
- Wilson Wong - OTH
- Ching Yu Yang - OTH
- Poh Tiong Koh - LED
- Tse Ghow Lim - NED
- Teik Lim Ang - NID
- Chuan Neo Chong - NID
- Teck Koon Kee - NID
- Yoong Keong Lew - NID
- Siang Keat Lim - NID
- Cheong Boon Png - NID
- Jao Yiu Sung - NID
- Wern Yuen Tan - NID